(Q43541519)

24 November 2017

The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy (English)

1 reference

24 November 2017

Hart KB

1

1 reference

24 November 2017

Wood DP Jr

2

1 reference

24 November 2017

Tekyi-Mensah S

3

1 reference

24 November 2017

Porter AT

4

1 reference

24 November 2017

Pontes JE

5

1 reference

24 November 2017

Forman JD

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

International Journal of Radiation Oncology Biology Physics

24 November 2017

1 reference

24 November 2017

45

1 reference

24 November 2017

5

1 reference

24 November 2017

1235-1238

1 reference

Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Radiation-treated carcinoma of prostate. Comparison of survival of black and white patients by Gleason's grading system.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Receptivity of African-American men to prostate cancer screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900321-1

7 January 2021

10.1016/S0360-3016(99)00321-1

Identifiers

DOI

1 reference

24 November 2017

1 reference